Fig. 7.

Pharmacological inhibition of MD2 by L6H9 reduces the development of atherosclerosis and inflammation in mice. (a) En face Oil Red O staining of aortas. Apoe^−/− mice maintained on HFD were treated with 10 mg/kg L6H9 every other day. Oil Red O staining highlighting neutral lipids (red). Lower panel showing quantification of plaque lesion area [n = 6]. (b) Oil Red O staining of lesion area in aortic sinus. Lower panel showing quantification of lesion area highlighted by Oil Red O staining [n = 6; scale bar = 500 μm]. (c) Representative images of α-SMA staining (red) of aortic sinus. Lower panel showing quantification of α-SMA staining area [n = 6; scale bar = 50 μm]. (d) Representative images of Masson's Trichome staining for collagen deposition. Lower panel showing quantification of fibrotic area [n = 6; scale bar = 50 μm]. (e) Serum levels of pro-inflammatory cytokines TNF-α and IL-6 [n = 6]. (f) Real-time qPCR assay shows the levels of mRNA of proinflammatory cytokines (Il-1β, Tnf-α, Il-6) and adhesion molecules (Icam-1, Vcam-1) in aortas [n = 6]. (g) Representative immunofluorescence staining images for CD68 (green) in aortic sinus. Tissues were counterstained with DAPI (blue) [scale bar = 50 μm]. (h) Quantification of CD68-positive area in aortic sinus slices [n = 4]. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)